MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
about
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current AssaysDiagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-AnalysisExtracellular microRNAs in urologic malignancies: chances and challengesCirculating microRNAs in cancer: origin, function and applicationMicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapyIn-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their InteractionsAltered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infectionSystematic analysis of microRNA targeting impacted by small insertions and deletions in human genome.Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.Expression of serum microRNA-378 and its clinical significance in renal cell carcinoma.microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells.Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.Renal cancer biomarkers: the promise of personalized careMicroRNA expression profiles of whole blood in lung adenocarcinomaVariation in dicer gene is associated with increased survival in T-cell lymphomamiR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancerMicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Circulating miRNAs in cancer: from detection to therapy.Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.The roles of microRNAs on tuberculosis infection: meaning or myth?Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.MicroRNA profiling of rats with ochratoxin A nephrotoxicity.Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancerAnalysis of plasma MicroRNAs to identifying early diagnostic molecule for gastric cancer.Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal CarcinomaCirculating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.miR-1290 is a potential prognostic biomarker in non-small cell lung cancerExpression and functional role of miR-29b in renal cell carcinoma.MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients.Human mirtrons can express functional microRNAs simultaneously from both arms in a flanking exon-independent manner.Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profilesProfiling analysis of circulating microRNA expression in cervical cancerSerum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinomaCentrifugation: an important pre-analytic procedure that influences plasma microRNA quantification during blood processing.
P2860
Q26777992-A84DDDBE-AAB2-4913-8BA1-146CF8901EA9Q26786185-CAA84166-25D1-45A2-A53B-36F4D5AED5EAQ26866043-A0AF7F5A-127B-4E7F-BB2E-C8D22A281BF7Q27013716-FACBF62C-A4E6-4F28-A2C8-7B8BA0A32AAFQ28538780-A82FF61B-620A-4273-9A85-FD3B1E333285Q28707993-B12DE62C-8E8A-482D-81E1-559CA92E17DDQ28709053-9D799CD4-EA49-41F7-B694-18822E9E905DQ31104377-256E1CF4-A562-42C3-91D2-8C11B0C0C9E5Q33838484-38983B91-25DC-4CD3-80AE-AD0DF9CB117EQ33846732-D2DC1F23-D3BC-44B1-B370-34A7DFCC4CC0Q33853224-9DCE24A9-3691-4C9F-8295-0BAF3A2D8AB2Q33947851-72F38F61-DBF8-4EF0-A486-7EABDA465ED0Q34028475-4AA7FD82-8547-412F-83B0-3D2948A43888Q34150859-FEB2CF33-D187-4C79-B5FE-631C028DCF31Q34202973-6B2986C9-1FD9-443A-ACC7-CE3DCAD8017CQ34273062-0AFCDEDE-6A7E-4843-BBAB-3DB7B7DF44BBQ34422845-B91CD213-CAAB-414D-AABD-70C0CA671611Q34430694-E990570C-FBAD-4F03-AB6D-D670C86FECE9Q34517073-B409394A-E0C5-45C9-94CE-DA88207E4907Q34544501-3787D9AC-1267-4C97-A940-3AB05A3E7418Q34599354-B037AA54-7FBC-489F-A0E3-4C6656021CECQ34728385-7EC90209-834E-4B46-BA58-EFBC6FD4D6EEQ34735084-9A2AE112-3DD2-4573-8070-B71D0937E343Q34846142-38CCB212-2471-4D33-9339-BA2696211269Q34985202-2A863C73-EEB8-4BF3-B6B1-0613802F7C9CQ35023641-6CECDE9E-3E76-420D-84FC-7E3952C6ED54Q35178777-87CD7B96-6E76-41A6-8CCA-1B36CE9B0880Q35189523-BD712343-DC74-4549-AD02-1ADCBA8B1F3CQ35643666-31C5ABAA-39CA-4413-BF40-7994BB1B3A7CQ35875417-5EE66DC1-FEBD-4E31-876E-54A8FEAC5E78Q35922727-20C03123-60CD-4D44-B8F9-003DF226189BQ36138340-D5BF7483-5E32-48F1-80A0-DD1D3FBA811DQ36464365-D8B2FFA8-2F0D-40C8-A103-BC3643295C18Q36522330-B000621C-ED48-4133-8868-616F593C4983Q36631220-FD2FC16D-C841-4ED2-83E8-BADCD2A279B2Q36840404-558013D7-365B-477A-BE82-14C03D64B613Q36931355-1BAD875E-B1E6-41CB-9002-4F0B6358069FQ37000943-4ACC44CF-0307-4BF9-8976-BA04161D674BQ37196131-84F83E26-B420-4996-984A-D28C567FA267Q37409781-97485155-E2F9-4F21-8E55-F14C8B7B63FB
P2860
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@ast
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@en
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@nl
type
label
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@ast
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@en
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@nl
prefLabel
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@ast
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@en
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@nl
P2093
P2860
P1433
P1476
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
@en
P2093
Alexander von Ruecker
Carsten Ohlmann
Edwin Herrmann
Frank Becker
Gisela Walgenbach-Brünagel
Jörg Ellinger
Lena M Wulfken
Rudolf Moritz
Stefan C Müller
Stefan Holdenrieder
P2860
P304
P356
10.1371/JOURNAL.PONE.0025787
P407
P577
2011-09-30T00:00:00Z